DIN 02231329 — APO-FLUVOXAMINE 50 MG
APO-FLUVOXAMINE is a tablet of Fluvoxamine marketed by APOTEX INC. The full Fluvoxamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02231329
- Brand name
- APO-FLUVOXAMINE
- Active ingredient
- Fluvoxamine
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Selective serotonin reuptake inhibitor (SSRI) antidepressant
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fluvoxamine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02231330 | APO-FLUVOXAMINE | 100 MG | TABLET | APOTEX INC | MARKETED |
| 01919369 | LUVOX | 100 MG | TABLET | BGP PHARMA ULC | MARKETED |
| 01919342 | LUVOX | 50 MG | TABLET | BGP PHARMA ULC | MARKETED |
| 02255537 | TEVA-FLUVOXAMINE | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02255529 | TEVA-FLUVOXAMINE | 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED |